Compare os principais médicos e preços de Terapia com células T CAR em Israel. Encontre o seu melhor par aqui.
Vamos selecionar os melhores médicos com base nas suas necessidades e orçamento.
Revisado por Fahad Mawlood
Editor médico e cientista de dadosMelhores médicos
7
Israel
Avaliações
14000+
De pacientes reais
Compare os preços de Terapia com células T CAR entre os principais países
Toque em um país para ver os principais médicos e preços
Receba planos de tratamento personalizados gratuitos e escolha a melhor opção. Sem compromisso · Sem pagamentos pelos nossos serviços
Mostrar primeiro:
O Dr. Ram Ron é especializado em terapia de células T CAR no Centro Médico Sourasky (Ichilov), trazendo vasta experiência para este tratamento avançado.
O Dr. Ron Ram realizou várias centenas de transplantes de células-tronco e publicou mais de 30 artigos científicos em hematologia e oncologia.
Chefe de Onco-Hematologia Pediátrica no Hospital Infantil Dana Dwek – A Dra. Ronit El Hasid é especializada em transplantes de medula óssea e sangue para crianças.
O Dr. Michael Shapira é especialista em Transplante de Medula Óssea no Sourasky Medical Center (Ichilov), com vasta experiência na área.
Diretor de hemato-oncologia pediátrica no Centro Médico Sourasky – especialista em terapia com células T CAR para crianças com distúrbios sanguíneos e sarcomas.
Com 31 anos de experiência, o Dr. Aviv é especialista em terapia com células T CAR no Centro Médico Sourasky (Clínica Ichilov).
O Dr. Yair fez contribuições significativas para a hematologia, particularmente na leucemia linfocítica crônica, com inúmeros prêmios e pesquisas publicadas.
Escolher clínica no exterior pode ser estressante. No Bookimed, com mais de 800K pacientes atendidos, entendemos preocupações. Sabemos encontrar médicos confiáveis, melhores opções de custo-benefício e soluções até para casos complexos. Estamos aqui para orientar em cada etapa.
Yan Matsiivskiy
Chefe da Equipe de Coordenadores Médicos
4300++ jornadas de pacientes acompanhadas
3 anos na Bookimed
142 pacientes de Israel encontraram seu médico conosco este mês
Quiz de 2 minutos
Conte-nos seu objetivo, orçamento e prazo
Combinação Humana + IA
Nosso algoritmo encontra correspondências, o coordenador verifica a adequação
Suas opções prontas
Compare preços, pacotes, datas. Converse com seu coordenador
Muitas opções?
Orientando seu tratamento
Coordenadores pessoais com formação médica
| Classificação | Médico | experiência | Bom para | O que os diferencia | Clínica e localização | Consulta |
|---|---|---|---|---|---|---|
| #1 | 24 anos de experiência | Terapia com células T CAR | Especializa-se em terapias celulares avançadas num centro de oncologia de referência, com foco em planos de tratamento personalizados. | Israel | Preço sob consulta | |
| #2 | 24 anos de experiência | Neoplasias hematológicas | Vasta experiência em transplantes de células-tronco, com contribuições acadêmicas, incluindo mais de 30 artigos publicados. Treinamento de subespecialidade (Fellowship) realizado no New York Medical College. | Israel | Preço sob consulta | |
| #3 | 38 anos de experiência | Terapia com células T CAR pediátrica | Lidera o departamento de transplante pediátrico, com mais de 300 transplantes realizados. Publicou mais de 50 artigos e é membro de associações importantes de hematologia. | Israel | Preço sob consulta | |
| #4 | 36 anos de experiência | Transplante de medula óssea | Especializado em Transplante de Medula Óssea, com vasta experiência de nível sênior. Treinamento realizado no prestigiado Centro Médico Hadassah e na Universidade Hebraica. | Israel | Preço sob consulta | |
| #5 | 41 anos de experiência | Distúrbios sanguíneos pediátricos e sarcomas | Lidera o departamento de oncologia e hematologia pediátrica de Sourasky – treinamento nos principais institutos globais para cânceres infantis. Coordena os programas de tratamento de sarcoma de Israel. | Israel | Preço sob consulta | |
| #6 | 34 anos de experiência | Terapia com células T CAR | É especialista em onco-hematologia, com décadas de experiência em terapias celulares avançadas. Trabalha no principal Centro Médico Sourasky de Israel. | Israel | Preço sob consulta | |
| #7 | 24 anos de experiência | Leucemia linfocítica crónica | Especializa-se em leucemia linfocítica crónica, tendo recebido múltiplos prémios e bolsas de investigação. Membro de associações de hematologia líderes. | Israel | Preço sob consulta |
You do not need a specific CAR T-cell referral to begin. Any hematologist or community oncologist can initiate the process to a specialized center. However, a multidisciplinary team at an accredited Israeli hospital must confirm your final eligibility for treatment.
Bookimed Expert Insight: While any hematologist can refer you, selecting a doctor with a high volume of related procedures speeds up valid documentation. For example, Dr. Ivetta Danylesko at Sheba Medical Center has performed over 3,000 procedures. Working with such experienced specialists helps ensure your medical history meets specific clinical trials or protocol requirements faster.
Patient Consensus: Patients note that pushing a local oncologist to refer directly to a CAR T-cell team can help bypass general queues. Many emphasize that having all previous treatment lines documented is vital for the multi-center board review. It is also common for patients to plan for a three to four month wait even after the initial referral.
Verify Israeli CAR T-cell therapy doctors by confirming their board certification in hematology and oncology through the Scientific Council of the Israel Medical Association. Leading specialists often hold international memberships in the American Society of Hematology and have completed fellowship training at top US institutions.
Bookimed Expert Insight: Data shows that premier Israeli specialists often hold significant leadership roles in global organizations. For instance, Dr. Arnon Nagler at Sheba Medical Center served as the Chair for the European Society for Blood and Marrow Transplantation (EBMT) committees. This level of international leadership indicates that these doctors don't just follow protocols but actually help create the global standards for CAR T-cell therapy and transplant medicine.
Patient Consensus: Patients mention that top-tier doctors are very open about sharing their personal results and response rates. They noticed that experienced specialists often have many co-author credits on major clinical trials. Families emphasize that the most skilled pediatric doctors have deep experience in handling complex cases at dedicated children's hospitals.
When choosing a CAR T-cell therapy doctor in Israel, you should look for board-certified hematologists and oncologists with specialized training in cellular immunotherapy. Leading experts often lead bone marrow transplant departments and have extensive experience in treating complex blood cancers like leukemia and lymphoma.
Bookimed Expert Insight: Data shows that premier Israeli specialists combine clinical leadership with heavy research involvement. For example, Prof. Arnon Nagler at Sheba Medical Center pioneered reduced-intensity transplant protocols. Choosing a doctor who also serves as a department director ensures they oversee the entire cell processing and recovery cycle at JCI-accredited facilities.
Patient Consensus: Patients often emphasize the importance of finding a doctor familiar with bridging therapies used before the actual cell infusion. They note that feeling supported by a team experienced in managing post-infusion side effects made their recovery much smoother. Many were relieved to work with specialists who have personal experience running clinical trials for the latest cellular products.
Major public medical centers in Israel like Sheba and Sourasky (Ichilov) staff board-certified hematologists with international fellowships in cellular immunotherapy. These facilities operate specialized units for CAR T-cell therapy. Experts here maintain credentials from the American Society of Hematology and other global bodies.
Bookimed Expert Insight: Data shows that Israeli public centers often feature surgeons who also lead specialized research departments. For example, Dr. Herishanu Yair at Sourasky heads the CLL Department while managing CAR T-cell protocols. This dual role means patients receive care from doctors who directly contribute to the latest clinical protocols and published research.
Patient Consensus: Patients note that doctors at these centers speak English at a level comparable to US specialists. They often mention the long 6-8 month waitlists for public slots but feel the advanced cellular facilities are worth the wait. Many are surprised by how quickly centers like Sheba can manufacture the cells on-site.
Private CAR T-cell therapy consultations with senior Israeli specialists typically range from $500 to $1,350. The public sector offers significantly lower costs for residents through health funds. However, private sessions provide immediate access to department heads and personalized treatment plans without the long wait times.
Bookimed Expert Insight: Data shows that senior specialists in Tel Aviv often maintain dual roles as department heads and private consultants. Dr. Fredi Aviv and Dr. Herishanu Yair bring over 25 years of experience to these sessions. Choosing a private consult at a center like Sourasky allows patients to bypass the standard 6-month public approval queue.
Patient Consensus: Patients note that while public sector co-pays are minimal, the bureaucracy can delay urgent care. Many choose private sessions to get a treatment plan started in days. They describe the experience as worth the cost for the direct time spent with a professor.
Patients should expect a high level of English proficiency from CAR T-cell therapy specialists in Israel. Most leading doctors hold American Board certifications or have completed fellowships at prestigious institutions like Stanford University and SUNY Brooklyn. Hospitals provide dedicated interpretation services for international patients to navigate complex treatment stages.
Bookimed Expert Insight: Data shows that senior hematologists in Israel often have dual training from both Israeli and North American institutions. For example, Dr. Arnon Nagler at Sheba Medical Center is a Stanford-trained pioneer, while Dr. Ronit El Hasid at Sourasky practiced at City of Hope in Los Angeles. This specific international background means they are comfortable using English as a primary language for medical discussions.
Patient Consensus: Patients find that while lead doctors speak excellent English, some nursing staff may have more limited language skills. Many suggest using a translation app for quick bedside needs but note that hospital coordinators are essential for understanding complex physician instructions.
Israel leads CAR T-cell innovation by running early-phase trials with homegrown constructs for blood cancers and solid tumors. Top experts like Dr. Ron Ram at Sourasky Medical Center (Ichilov) and specialists at Sheba Medical Center develop proprietary vectors. These programs often provide faster access than commercial therapies from the US.
Bookimed Expert Insight: A unique pattern in Israel is the integration of high-level international training within local research clinics. For example, Dr. Ron Ram and Dr. Arnon Nagler both completed fellowships at Stanford University, while Dr. Ronit El Hasid trained at City of Hope. This global expertise allows Israeli centers to successfully run dual US-Israel clinical trials for complex off-the-shelf and bispecific CAR-T products.
Patient Consensus: Patients note that Israeli doctors often provide access to logic-gated constructs after US programs decline their cases. Relatives say the medical teams quickly manage side effects like cytokine release syndrome during phase 1 trials. Many emphasize having a translator ready because consent forms for early-stage studies are frequently in Hebrew.